Your browser doesn't support javascript.
loading
Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study.
Gane, Edward; Verdon, Daniel J; Brooks, Anna E; Gaggar, Anuj; Nguyen, Anh Hoa; Subramanian, G Mani; Schwabe, Christian; Dunbar, P Rod.
Afiliação
  • Gane E; Auckland Clinical Studies, Auckland, New Zealand. Electronic address: edgane@adhb.govt.nz.
  • Verdon DJ; School of Biological Sciences, and Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Brooks AE; School of Biological Sciences, and Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
  • Gaggar A; Gilead Sciences, Inc., Foster City, CA, USA.
  • Nguyen AH; Gilead Sciences, Inc., Foster City, CA, USA.
  • Subramanian GM; Gilead Sciences, Inc., Foster City, CA, USA.
  • Schwabe C; Auckland Clinical Studies, Auckland, New Zealand.
  • Dunbar PR; School of Biological Sciences, and Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
J Hepatol ; 71(5): 900-907, 2019 11.
Article em En | MEDLINE | ID: mdl-31306680

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Vacinação / Vacinas contra Hepatite B / Hepatite B Crônica / Receptor de Morte Celular Programada 1 / Nivolumabe / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Vacinação / Vacinas contra Hepatite B / Hepatite B Crônica / Receptor de Morte Celular Programada 1 / Nivolumabe / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2019 Tipo de documento: Article